Parabilis Medicines, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | -11.1% | +25.3% | +4.3% | |
| – | +0.9% | +51.7% | +20.2% | |
| – | -10.8% | +32.2% | +7.5% | |
| – | – | – | – | |
| – | -0.8% | -26.3% | -28.1% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.